Aviso: Este site agrega dados públicos oficiais da FDA, ClinicalTrials.gov, PubMed e SEC EDGAR apenas para referência geral. Não constitui aconselhamento médico, diagnóstico, recomendação de tratamento ou aconselhamento de investimento.

FDA PMA

Endovascular system for treatment of thoracoabdominal and pararenal aortic lesions

Número do PMA: P230023 · 2026-07-01

RequerenteW. L. Gore & Associates, Inc.
Data da decisão2026-07-01
Número PMAP230023
Código do produtoQZK
Classe do DispositivoClasse 3
Especialidade MédicaU
Comité consultivoCV

Resumo do dispositivo

Endovascular system for treatment of thoracoabdominal and pararenal aortic lesions is the device name listed in this FDA 510(k) record. The listed applicant is W. L. Gore & Associates, Inc.. It received FDA 510(k) clearance on 2026-07-01. The device is classified under product code QZK. It was reviewed by the CV advisory panel.

Perguntas frequentes

What is the Endovascular system for treatment of thoracoabdominal and pararenal aortic lesions?

Endovascular system for treatment of thoracoabdominal and pararenal aortic lesions is a medical device that received FDA 510(k) clearance on 2026-07-01. The listed applicant is W. L. Gore & Associates, Inc..

When did Endovascular system for treatment of thoracoabdominal and pararenal aortic lesions receive FDA 510(k) clearance?

The clearance date for Endovascular system for treatment of thoracoabdominal and pararenal aortic lesions can be found in the official FDA records.

Who is the listed applicant for Endovascular system for treatment of thoracoabdominal and pararenal aortic lesions?

The FDA 510(k) record lists W. L. Gore & Associates, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Endovascular system for treatment of thoracoabdominal and pararenal aortic lesions?

The FDA product code for Endovascular system for treatment of thoracoabdominal and pararenal aortic lesions is QZK.

Ensaios clínicos relacionados

Registros relacionados são pareados automaticamente usando nomes, códigos de produtos ou outros metadados. Um pareamento não estabelece um vínculo clínico, científico, corporativo ou regulatório verificado; revise as fontes oficiais vinculadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fonte oficial

Ver na base de dados da FDA →

Dados provenientes da FDA Open API. Para informações mais recentes e oficiais, consulte sempre o registro oficial.

↑